---
document_datetime: 2025-07-11 14:17:27
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/epoetin-alfa-hexal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: epoetin-alfa-hexal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.1889964
conversion_datetime: 2025-12-25 02:59:52.811493
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Epoetin alfa Hexal

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber    | Scope                               | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|-------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | B.II.b.2.cReplacementor additionofa | 11/07/2025                          |                                          | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000278097                     | manufacturerresponsibleforimportation and/or batch release - B.11.b.2.c.1 Not includingbatchcontrol/testing-Accepted                                                                                                     |            |     | PL   |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| Variation type IA / EMA/VR/0000265273 | B.II1.2 Change to comply with Ph.Eur.or withanationalpharmacopoeiaofaMember State-B.IIl.2.bChange tocomplywith an update of the relevant monograph of the Ph. Eur.or national pharmacopoeia of a Member State - Accepted | 16/04/2025 | N/A |      |